Condition
Stage IVB Lip and Oral Cavity Cancer AJCC v8 clinical trials and research
Research outlook What's coming for Oral cavity cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Stage IVB Lip and Oral Cavity Cancer AJCC v8 clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Canada (1)). By phase: Phase 1 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Stage IVB Lip and Oral Cavity Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Camonsertib added to precise radiation therapy for recurrent head and neck cancer | Phase 1 | Duarte, California and 3 other locations | Recruiting | Sep 5, 2025 |
| Cemiplimab with or without CDX-1140 given before surgery for stage III-IV head and neck cancer | Phase 2 | Irvine, California and 11 other locations | Recruiting | May 20, 2025 |
| Adding BMX-001, a drug that protects normal tissue from radiation damage, to standard chemoradiation for head and neck cancer | Phase 2 | Gilbert, Arizona and 152 other locations | Recruiting | Aug 1, 2024 |
| Combining Ipatasertib with Chemotherapy and Radiation for Head and Neck Cancer | Phase 1 | Tampa, Florida and 17 other locations | Recruiting | Dec 29, 2021 |
All recruiting trials (4)
-
Camonsertib added to precise radiation therapy for recurrent head and neck cancer
This early-phase study tests whether the cancer drug camonsertib, given with targeted SBRT radiation, is safe and tolerable for people with recurrent or unresectable head and neck squamous cell carcinoma.
-
Cemiplimab with or without CDX-1140 given before surgery for stage III-IV head and neck cancer
This trial tests whether adding the immune stimulant CDX-1140 to cemiplimab before surgery helps shrink tumors in people with resectable stage III-IV head and neck squamous cell carcinoma.
-
Adding BMX-001, a drug that protects normal tissue from radiation damage, to standard chemoradiation for head and neck cancer
This trial tests whether giving BMX-001 along with usual mouth-care reduces severe mouth sores in people getting cisplatin-based chemoradiation for HPV-related and other head and neck cancers.
-
Combining Ipatasertib with Chemotherapy and Radiation for Head and Neck Cancer
This study is testing if adding a new drug called ipatasertib to chemotherapy and radiation can help people with advanced head and neck cancer feel better and improve their treatment results.
Related topics
Quick answers
How many Stage IVB Lip and Oral Cavity Cancer AJCC v8 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.